- Home
- CODI vs MDXG Comparison
CODI vs MDXG Comparison
Compare CODI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CODI | MDXG |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 835.1M | 672.8M |
| IPO Year | 2005 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CODI | MDXG |
|---|---|---|
| Price | $10.86 | $4.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $17.00 | $7.40 |
| AVG Volume (30 Days) | 483.5K | ★ 976.3K |
| Earning Date | 08-10-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $1,560,757,000.00 | $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.59 | $21.78 |
| P/E Ratio | $35.23 | ★ N/A |
| Revenue Growth | 7.62 | ★ 19.99 |
| 52 Week Low | $4.58 | $3.03 |
| 52 Week High | $13.25 | $7.97 |
Technical Indicators
Market Signals| Indicator | CODI | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 53.33 |
| Support Level | $10.87 | $4.37 |
| Resistance Level | $11.02 | $4.76 |
| Average True Range (ATR) | 0.30 | 0.16 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 40.38 | 42.37 |
Price Performance
Historical ComparisonAbout CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.